Etodolac Tablets USP, 400mg
Company: Royce Laboratories
Approval Status: Approved April 1997
Treatment for: rheumatoid arthritis
Areas: Endocrinology; Rheumatology
Possible similar drugs: Etodolac 200mg and 300mg; Etodolac tablets
| General Information | Clinical Results |
General Information
Etodolac Tablets USP, 400mg, have been approved for the treatment of rheumatoid arthritis. Etodolac is the generic equivalent of Wyeth Ayerst’s Lodine Tablets. Etodolac was earlier approved for treating osteoarthritis and managing pain.
Clinical Results
The safety and efficacy for treating rheumatoid arthritis was established in a 3 year double-blind, mulitcenter trial of 1446 patients. In the study 1000mg/day was effective and well tolerated. The recommended starting dose is 600-1000mg/day, divided into two or three doses.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
